Insight and investigations from our expert reporters
When former beauty queen Anita Bryant chirped more than four decades ago: “A day without orange juice is like a day without sunshine,” she wasn’t talking about green oranges or genetically altered ones, but that was then.
Now, an insect-borne bacterial disease known as “greening” threatens the very survival of Florida’s $9 billion citrus industry. Calvin Arnold, a scientist with the U.S. Department of Agriculture, believes genetic engineering holds the only hope for a cure.
Also known as Huanglongbing (HLB), or “yellow dragon disease,” greening was identified in China more than a century ago and has no known cure. It is spread by a very small bug called a psyllid.
BOSTON – A battle royal is shaping up in the world of exchange-traded funds. After years of trailing in the race to attract new money from ETF investors, fund giant Vanguard is poised to take the top spot from iShares this year. But the big winners will be investors who are seeing fees plummet.
Aaron Pressman looks at the winners and losers in his special report “What did you do in the ETF war, daddy?”
Two graphs tell an apparently conflicting story: analysts forecast a steady recovery in BP’s dividends, but its valuation remains weak. Tom Bergin’s close look at the potential costs facing BP as a result of its Gulf of Mexico oil spill helps explain the latter, but less so the former.